Summary
Cannabinoids have significant anticonvulsant effects, the mechanism of which is obscure. In addition, these agents reduce intraocular pressure. Inhibitors of carbonic anhydrase also share these two pharmacological actions. In order to investigate whether these actions of Cannabinoids are mediated through inhibition of carbonic anhydrase (CA), commercial solutions of the enzyme were exposed to Δ9-tetrahydrocannabinol and cannabidiol. No inhibition was observed at concentrations of 10−7–10−6 M.
This is a preview of subscription content, log in via an institution to check access.
References
Armstrong, Mc. D., Myers, D. V., Verpoorte, J. A., Edsall, J. T. Purification and properties of human erythrocyte carbonic anhydrases. J. Biol. Chem.24, 5137–5149 (1966).
Bbargava, N. H. Potential therapeutic application of naturally occurring and synthetic cannabinoids. Gen. Pharmacol.9, 195–213 (1978).
Green, K., Kim, K. Mediation of ocular tetrahydrocannabinol effects by adrenergic nervous system. Exp. Eye Res.23, 443–448 (1976).
Helper, R. S., Frank, I. M. Marihuana smoking and intraocular pressure. J. Am. Med. Assoc.217, 1392 (1971).
Korczyn, A. D.: The ocular effects of cannabinoids. General Pharmacology, 1980. (Accepted for publication.)
Macri, F. J., Cervario, S. J. A possible vascular mechanism for the inhibition of aqueous humor formation by ouabain and acetazolamide. Exp. Eye Res.20, 563–569 (1975).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maor, D., Treves, T. & Korczyn, A.D. Lack of effect of cannabinoids on carbonic anhydrase. J. Neural Transmission 49, 205–206 (1980). https://doi.org/10.1007/BF01245226
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01245226